吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Oct 27 2017

Full Issue

Insys Founder Charged With Felonies Involving 'Nationwide Conspiracy' To Push Powerful Opioids

Prosecutors allege John N. Kapoor had been bribing doctors to prescribe his company's drug intended for cancer patients only.

The founder of an Arizona-based pharmaceutical company has been charged with spearheading a 鈥渘ationwide conspiracy鈥 to illegally distribute fentanyl, a powerful prescription painkiller. John N. Kapoor, 74, was charged with numerous felonies, including RICO (Racketeer Influenced and Corrupt Organization) conspiracy and wire fraud. Prosecutors allege Kapoor,聽the founder of Insys Pharmaceuticals, colluded with doctors and pharmacies to prescribe fentanyl that was not medically necessary and defraud insurance companies for payment. (Zezima, 10/26)

The case naming Kapoor follows indictments against the company鈥檚 former CEO and other executives and managers on allegations that they provided kickbacks to doctors to prescribe a potent opioid called Subsys. In the new indictment, Kapoor, 74, of Phoenix, and the other defendants are accused of offering bribes to doctors to write large numbers of prescriptions for the fentanyl-based pain medication that is meant only for cancer patients with severe pain. Most of the people who received prescriptions did not have cancer. (Snow and Davenport, 10/26)

Speakers鈥 fees, dinners, entertainment, cash -- federal charges unsealed Thursday claim Kapoor鈥檚 striving company, Insys Therapeutics Inc., employed all of that and more to spur prescriptions of a highly addictive fentanyl-based drug intended only for cancer patients. (Koons and Feeley, 10/26)

鈥淚n the midst of a nationwide opioid epidemic that has reached crisis proportions, Mr. Kapoor and his company stand accused of bribing doctors to overprescribe a potent opioid and committing fraud on insurance companies solely for profit,鈥 acting U.S. Attorney William D. Weinreb said in a statement. (Swetlitz, 10/26)

In Massachusetts, former Insys CEO Michael L. Babich and five other former executives and managers are set to go to trial in October 2018 and have pleaded not guilty. The latest indictment brings new charges against Babich and others. (Snow and Davenport, 10/26)

In other news聽鈥

U.S. Attorney General Jeff Sessions equated the opioid epidemic to a personal failing by many Americans who cannot "say no" to drugs on Thursday, and he said that marijuana could be serving as a gateway to the problem. "People should say no to drug use. They have got to protect themselves first," he said during a question-and-answer session at the Heritage Foundation think tank in Washington. (Lynch, 10/26)

The number of Americans dying from drug overdoses jumped by more than 200 percent in the last 16 years, a spike that crosses economic, geographic and racial lines. More than 52,000 Americans died of a drug overdose in 2015, according to the Centers for Disease Control and Prevention. That鈥檚 211 percent higher than the 16,849 people who died of overdoses in 1999 and double the 25,785 who died that way in 2003. (Wilson, 10/26)

Courtrooms aren鈥檛 the place to fix the opioid epidemic, said a top drug distributor targeted by numerous lawsuits from cities and states claiming it played a role in the crisis. 鈥淔rankly, lawsuits from various parties and settlements don鈥檛 solve the problem,鈥澛爏aid John Hammergren, the chief executive of McKesson Corp., in discussing quarterly results on a call with analysts Thursday. 鈥淲hat solves the problem is thinking in a broader context and putting the solutions in place that they can actually prevent this from happening.鈥 (Hopkins, 10/26)

It has the power to save lives by targeting opioid overdoses 鈥 something that kills more than 140 Americans every day. And now Narcan, the nasal spray that can pull a drug user back from an overdose, is being carried by all of Walgreens' more than 8,000 pharmacies. "By stocking Narcan in all our pharmacies, we are making it easier for families and caregivers to help their loved ones by having it on hand in case it is needed," said Walgreens vice president Rick Gates. (Chappell, 10/26)

Have unwanted or unused prescription drugs taking up room in your medicine cabinet? Police departments across South Florida are taking part in the Drug Enforcement Administration's National Prescription Drug Take-Back Day from 10 a.m. to 2 p.m. Saturday. That means people can drop off prescription drugs with no questions asked. (Teproff, 10/26)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, August 5
  • Tuesday, August 4
  • Monday, August 3
  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF